Home > Drug Search >
  • company_query: Alexar Therapeutics
  •   > 
Drug Filter
Category:
chemistry (10) biology (14)
Status:
Approved (2) Withdrawn (1) Phase Ⅲ (1) Phase Ⅱ (15) Phase Ⅰ (5)
Clinical Stage:
Pending (4) Active (13) Discontinued (4)
Bio-Type:
Cell therapy (1) Vaccine (8) Recombinant cytokines (1) Recombinant hormone (1) Other recombinant protein (1) Whole antibody (1)
Indication:
Acute lymphoblastic leukaemia (ALL) (1) Advanced renal cell carcinoma (RCC) (1) Alzheimer's disease (AD) (2) Anemia (1) Atopic dermatitis (1) Breast cancer (2) Community-acquired pneumonia (CAP) (1) Cystic fibrosis (CF) (1) Bronchitis (1) Diabetic macular edema (1) Diarrhea (1) Retinal disorders (1) Cytomegalovirus infections (1) HIV infection (1) Inflammatory bowel disease (1) Rabies (1) Melanoma (1) Non small cell lung cancer (NSCLC) (1) Ovarian cancer (1) Pancreatic cancer (2) Prostate cancer (2) Renal cell carcinoma (1) Solid tumours (2) Age-related macular degeneration (AMD) (1) Methicillin-resistant staphylococcus aureus infections (1) Systemic inflammatory response syndrome (SIRS) (1) Hematological cancer (1) Advanced melanoma (1) Bleeding (1) Diabetic retinopathy (1) Cocaine abuse (1)
Country:
Aprv. Year:
 (1) 1997 (1) 2012 (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top